Building a new model for earlier Alzheimer’s diagnosis and care

A new clinical service for people at risk of or in the early stages of Alzheimer’s disease and other neurodegenerative conditions.  

Scottish patients first in Europe to join new Alzheimer’s trial focused on reducing distress

Study is open for recruitment in Aberdeen and Edinburgh. Learn more

Introducing Gary White as Director of Operations

Life sciences expert Gary White appointed as Director of Operations at Scottish Brain Sciences to support company growth.

Alzheimer’s blood and biomarker testing service launched to support earlier diagnosis

Service will be available to clinicians and healthcare providers to support patient assessments and diagnosis. Contact the lab for more details.

International Brain Health Conference 2026 highlights

Highlights from the first International Brain Health Conference 2026.

Scottish Brain Sciences Biomarker Laboratory Achieves ISO 15189 Accreditation

Scottish Brain Sciences has achieved UKAS ISO 15189 accreditation, marking a major milestone in its mission to advance the early detection and diagnosis of Alzheimer’s disease.

Introducing Lewis Penny, new Director of Laboratory Sciences

Dr Lewis Penny is leading the Laboratory Services from our state of the art lab in St Andrews. Contact Lewis for Lab Services enquiries.

International Brain Health Conference 2026 to spotlight early intervention in dementia prevention

Edinburgh will host a major new global brain health event for researchers, clinicians and policymakers in May 2026. Register for tickets.

Championing technology to detect declining brain health earlier

Using next-generation imaging to improve brain disease detection. Find out about the University of Aberdeen PUFFINS study we are supporting.

Aberdeen FC partnership shines a spotlight on brain research in the north east

Community engagement as match sponsor for Aberdeen FC. Join our brain health research in Aberdeen.